MEVIS MEDICAL SOLUTIONS AG
DGAP-News: MeVis Medical Solutions AG / Key word(s): Personnel Bremen, May 7, 2019 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, announces a change in its Executive Board. As of April 1, 2019, Marcus Kirchhoff has taken over as sole member of the Executive Board of MeVis Medical Solutions AG. Kirchhoff was appointed to the Executive Board in 2012 as CEO and, in addition to his previous activities in this function, will now also be responsible for oversight of Finance, Human Resources and IT activities. The former Chief Financial Officer Dr. Robert Hannemann left the company at his own request and reached an agreement with the Supervisory Board on the premature termination of his mandate. The Executive Board and Supervisory Board would like to thank Dr. Hannemann for his dedicated work over more than 8 years. "Dr. Robert Hannemann has played a decisive role in co-managing the company constructively and with great commitment. Especially during and after the takeover by the current majority shareholder, Varex Imaging Corporation, Dr. Hannemann made a significant contribution with his expertise and competence. On behalf of the entire Supervisory Board, I would also like to thank him personally for his years of untiring commitment," emphasized Kim Honeysett, Chairperson of the Supervisory Board. "We wish Dr. Hannemann all the best for the future. The management of MeVis Medical Solutions AG will now be led by Marcus Kirchhoff, as sole Executive Board member, and his experienced capable management team. We know and appreciate Mr. Kirchhoff from the good cooperation so far and look forward to a continued successful future of the company under his leadership." ************************************************************************ Contact:Kirchhoff, Marcus / CEO
07.05.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
| Language: | English |
| Company: | MeVis Medical Solutions AG |
| Caroline-Herschel-Str. 1 | |
| 28359 Bremen | |
| Germany | |
| Phone: | +49 421 224 95 0 |
| Fax: | +49 421 224 95 999 |
| E-mail: | ir@mevis.de |
| Internet: | http://www.mevis.de |
| ISIN: | DE000A0LBFE4 |
| WKN: | A0LBFE |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 808285 |
| End of News | DGAP News Service |
808285 07.05.2019
